Company · CIK 1710072

# Edgewise Therapeutics, Inc.

| CIK | [1710072](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001710072) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CO |
| Listed | EWTX (Nasdaq) |
| First annual or quarterly report | 2021-05-13 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-279299 | Shelf Effective | 2024-05-10 | 2025-04-02 | 2 |
| 333-264083 | Shelf Effective | 2022-04-01 | 2024-01-19 | 7 |
| 333-253923 | IPO Final prospectus | 2021-03-05 | 2021-03-26 | 5 |

## Filings

 15

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-04-02 | [424B5](https://www.sec.gov/Archives/edgar/data/1710072/000110465925031266/0001104659-25-031266-index.htm) Shelf takedown | 333-279299 | 0001104659-25-031266 |
| 2024-05-10 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1710072/000110465924059673/0001104659-24-059673-index.htm) Shelf registered | 333-279299 | 0001104659-24-059673 |
| 2024-01-19 | [424B5](https://www.sec.gov/Archives/edgar/data/1710072/000110465924005260/0001104659-24-005260-index.htm) Shelf takedown | 333-264083 | 0001104659-24-005260 |
| 2023-06-16 | [424B5](https://www.sec.gov/Archives/edgar/data/1710072/000110465923072226/0001104659-23-072226-index.htm) Shelf takedown | 333-264083 | 0001104659-23-072226 |
| 2022-09-14 | [424B5](https://www.sec.gov/Archives/edgar/data/1710072/000110465922100073/0001104659-22-100073-index.htm) Shelf takedown | 333-264083 | 0001104659-22-100073 |
| 2022-09-13 | [424B5](https://www.sec.gov/Archives/edgar/data/1710072/000110465922099497/0001104659-22-099497-index.htm) Shelf takedown | 333-264083 | 0001104659-22-099497 |
| 2022-05-05 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1710072/999999999522001328/9999999995-22-001328-index.htm) Declared effective | 333-264083 | 9999999995-22-001328 |
| 2022-05-05 | [424B5](https://www.sec.gov/Archives/edgar/data/1710072/000110465922056528/0001104659-22-056528-index.htm) Shelf takedown | 333-264083 | 0001104659-22-056528 |
| 2022-04-01 | [S-3](https://www.sec.gov/Archives/edgar/data/1710072/000110465922041797/0001104659-22-041797-index.htm) Shelf registered | 333-264083 | 0001104659-22-041797 |
| 2021-03-26 | [424B4](https://www.sec.gov/Archives/edgar/data/1710072/000110465921042550/0001104659-21-042550-index.htm) Final prospectus | 333-253923 | 0001104659-21-042550 |
| 2021-03-25 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1710072/999999999521001139/9999999995-21-001139-index.htm) Declared effective | 333-253923 | 9999999995-21-001139 |
| 2021-03-24 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1710072/000110465921040745/0001104659-21-040745-index.htm) Amendment | 333-253923 | 0001104659-21-040745 |
| 2021-03-22 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1710072/000110465921039429/0001104659-21-039429-index.htm) Amendment | 333-253923 | 0001104659-21-039429 |
| 2021-03-05 | [S-1](https://www.sec.gov/Archives/edgar/data/1710072/000110465921032712/0001104659-21-032712-index.htm) Registration filed | 333-253923 | 0001104659-21-032712 |
| 2020-12-18 | [DRS](https://www.sec.gov/Archives/edgar/data/1710072/000110465920137501/0001104659-20-137501-index.htm) Draft made public | 377-03916 | 0001104659-20-137501 |

[All filings of this company](https://equitycapital.markets/filings?cik=1710072) · [CSV](https://equitycapital.markets/filings.csv?cik=1710072)

---
Source page: https://equitycapital.markets/company/1710072 · Data: U.S. SEC EDGAR · CC BY 4.0